News Item
The U.S. has agreed to pay Pfizer Inc. and BioNTech nearly $2 billion to secure 100 million doses of their experimental Covid-19 vaccine to provide to Americans free of charge.
Under the $1.95 billion agreement, the U.S. Department of Health and Human Services and the Defense Department will receive 100 million doses of the vaccine should it be cleared by regulators, and can also acquire an additional 500 million doses. The vaccine, which has shown promising preliminary results in small groups of patients, is set to enter late-stage testing this month.